Commonly used painkillers to promote cancerNarcotic painkillers-based show to promote the development of cancer. Two new studies show that cell lung cancer by blocking the opiate to reduce cell proliferation, invasion and migration, as well as in cell cultures and mouse models.
Dr said: "Patrick Singleton, assistant professor of medicine at the University of Chicago Medical Center and head of the two studies.
"This shows that the potential new applications, this new class of drugs to consider," he added.
A palliative care survey in 2002 showed that patients who received spinal analgesia than systemic last longer. Shortly thereafter, fellow anesthesia Singleton Jonathan Moss, noting that some cancer patients with opioid selective blocker of loving protocol lasted longer than expected.
Moss palliative care for patients methylnaltrexone (MNTX), which was developed in 1980 for opiate-induced constipation in the late University of Chicago pharmacologist Leon Goldberg. Edited he found a substance that blocks the morphine so that you can not pass the protective barrier around the brain.
Dr said: "Patrick Singleton, assistant professor of medicine at the University of Chicago Medical Center and head of the two studies.
"This shows that the potential new applications, this new class of drugs to consider," he added.
A palliative care survey in 2002 showed that patients who received spinal analgesia than systemic last longer. Shortly thereafter, fellow anesthesia Singleton Jonathan Moss, noting that some cancer patients with opioid selective blocker of loving protocol lasted longer than expected.
Moss palliative care for patients methylnaltrexone (MNTX), which was developed in 1980 for opiate-induced constipation in the late University of Chicago pharmacologist Leon Goldberg. Edited he found a substance that blocks the morphine so that you can not pass the protective barrier around the brain.
No comments:
Post a Comment